Mohammad Ali Nilforoushzadeh

Mohammad Ali Nilforoushzadeh

Auto-generated profile, based on publicly available information

Mohammad Ali Nilforoushzadeh

Skin and Stem Cell Research Center, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in Microbial Pathogenesis
Verified
Journal Article
Closed access
MAMaryam Aghaei
Maryam Aghaei
HKHossein Khanahmad
Hossein Khanahmad
SAShahrzad Aghaei
Shahrzad Aghaei
MNMohammad Ali Nilforoushzadeh
Mohammad Ali Nilforoushzadeh
MMMohammad-Ali Mohaghegh
Mohammad-Ali Mohaghegh
SHseyed hossein Hejazi
seyed hossein Hejazi

18 May 2019 in Journal of Cosmetic Dermatology
Verified
Journal Article
Closed access
PDF file
AAAli Asilian
Ali Asilian
GFGita Faghihi
Gita Faghihi
AEAlireza Asemi Esfahani
Alireza Asemi Esfahani
FMFatemeh Mokhtari
Fatemeh Mokhtari
MNMohammadali Nilforoushzadeh
Mohammadali Nilforoushzadeh
SMSamaneh Mozafarpoor
Samaneh Mozafarpoor

1 November 2023 in Journal of lasers in medical sciences
Verified
Journal Article
Open access
PDF file
PMParvin Mansouri
Parvin Mansouri
MRMohammadreza Rahbar
Mohammadreza Rahbar
MNMohammad Ali Nilforoushzadeh
Mohammad Ali Nilforoushzadeh
MSMohsen Shati
Mohsen Shati
Introduction: Vitiligo, a dermatological disorder that leads to depigmented skin patches, presents a significant challenge, particularly in resistant areas such as acral regions. Fractional CO2 laser therapy holds promise as an adjunct to conventional treatment, enhancing repigmentation. This review comprehensively explores its efficacy and safety in resistant-to-treatment vitiligo. Methods: We conducted extensive database searches in PubMed, Embase, and Cochrane, focusing on English-language literature published between 2012 and 2023. We included comparative studies that met the following criteria: (1) Participants had non-segmental vitiligo, with resistant-to-treatment localization engagement; (2) The treatment involved the use of fractional CO2 laser in combination with conventional therapies; and (3) Outcomes were assessed based on the repigmentation ratio or significant difference. We excluded studies from which data from published results could not be extracted. Results: After extensive screening of 52 articles, we finally selected five studies. The results showed that fractional CO2 laser therapy, when combined with other treatments, often shows promise in vitiligo treatment in refractory cases. Although individual responses varied, overall efficacy and safety were promising, with minimal adverse effects and no severe complications. Conclusion: The fractional CO2 laser, when used in conjunction with conventional therapies, emerges as a promising option for treating refractory vitiligo. Large-scale randomized trials and a deeper understanding of the underlying mechanisms are vital for future progress in optimizing treatment protocols, case selection, and safety.

10 August 2024 in Journal of lasers in medical sciences
Verified
Journal Article
Closed access
PMParvin Mansouri
Parvin Mansouri
MRMohammadreza Rahbar
Mohammadreza Rahbar
MNMohammad Ali Nilforoushzadeh
Mohammad Ali Nilforoushzadeh
MSMohsen Shati
Mohsen Shati
MAMohammad Amir Amirkhani
Mohammad Amir Amirkhani
Introduction: Vitiligo poses a significant challenge, particularly in treatment-resistant areas such as acral regions. This study aimed to evaluate the effectiveness and safety of combining fractional CO2 laser and microneedling with conventional therapies for non-segmental vitiligo in resistant areas. Methods: A randomized clinical trial with a paired design was conducted on 84 individuals with non-segmental vitiligo and treatment-resistant lesions. Participants in two separate groups received various combinations of interventions, including narrowband ultraviolet B (NB-UVB) and topical steroid (Clobetasol ointment) as conventional treatments, with fractional CO2 laser or microneedling as add-ons for four symmetrical treatment-resistant lesions. The treatment duration was 16 weeks, followed by observation until six months post-intervention for each patient, and it focused on assessing the percentage of repigmentation, safety, patient satisfaction, and potential adverse effects. Results: The results of the study revealed a significant difference in average efficacy, with treatments involving fractional CO2 laser and microneedling compared with other interventions without them showing a higher percentage of repigmentation. No notable distinction in repigmentation patterns was observed, except for slightly higher marginal repigmentation with microneedling. Side effects, including pain, burning sensation, and erythema, were more frequent, with no significant difference between the groups. Itching and crusting had a significant difference in the two groups. Patient satisfaction levels were comparable, with the first group slightly more than the second. Conclusion: In conclusion, combining NB-UVB and topical steroid therapies with the fractional CO2 laser or microneedling seems to be effective for vitiligo treatment in resistant areas. Attention to variations in patients’ characteristics and specific body locations is necessary when applying these modalities. This study provides valuable insights into novel approaches for managing vitiligo and highlights the potential benefits of these innovative treatments in combination with conventional therapy.

15 February 2026 in Journal of Skin and Stem Cell
Verified
Journal Article
Open access
MGMaryam Golparvaran
Maryam Golparvaran
SSShahram Shahram
Shahram Shahram
MNMohammad Ali Nilforoushzadeh
Mohammad Ali Nilforoushzadeh
FKFarah Lotfi Kashani
Farah Lotfi Kashani
Background: Cosmetic procedures have raised interest in the psychological profiles of beauty clinic clients. Understanding their mental and behavioral health compared to the general population can help inform appropriate screening and clinical decision-making. Objectives: This study compares the prevalence and severity of psychological symptoms between beauty clinic clients and individuals from the general population. Methods: A cross-sectional study was conducted with 400 participants: 200 beauty clinic clients and 200 individuals from the general population in Tehran. Behavioral symptoms were assessed using the Symptom Checklist-90 (SCL-90). Descriptive statistics and inferential analyses (independent t-tests, chi-square) were used. Results: Significant differences in demographic characteristics were observed between the two groups (P < 0.001). Individuals from the general population reported higher levels of anxiety, obsessive–compulsive symptoms, interpersonal sensitivity, and psychosis (P < 0.05). No significant group differences were found for depression, somatization, aggression, phobia, or paranoid ideation. After adjustment for demographic variables, group differences remained evident for some psychological symptom domains. Conclusions: Contrary to common assumptions, beauty clinic clients in this sample did not exhibit higher levels of psychological symptoms compared with the general population. These findings should be interpreted descriptively rather than causally, as residual confounding cannot be fully excluded despite demographic adjustment. Overall, cosmetic interest does not appear to be inherently associated with elevated psychological distress. Incorporating routine psychological symptom screening in cosmetic settings may support ethically informed clinical decision-making and help identify individuals who may benefit from further psychological evaluation.

28 May 2026 in Journal of Cosmetic Dermatology
Verified
Journal Article
Open access
PDF file
MGMaryam Golparvaran
Maryam Golparvaran
SVShahram Vaziri
Shahram Vaziri
MNMohammad Ali Nilforoushzadeh
Mohammad Ali Nilforoushzadeh
FKFarah Lotfi Kashani
Farah Lotfi Kashani
Background: Body satisfaction is an important factor influencing interest in cosmetic and aesthetic procedures and is shaped by body mass index (BMI) and psychological symptom dimensions. Evidence on their combined associations in cosmetic clinic populations remains limited. Aims: To examine associations between psychological symptom dimensions and BMI with body satisfaction among beauty clinic clients in Tehran compared with the general population. Methods: In this cross‐sectional study, 400 participants (200 beauty clinic clients and 200 from the general population) completed the Symptom Checklist‐90 and the Body Image Satisfaction Questionnaire. BMI was calculated from self‐reported height and weight. Group comparisons and multiple linear regression analyses were conducted. The groups differed substantially in gender composition, which was considered in interpretation. Results: Beauty clinic clients reported higher depressive symptoms but lower anxiety and interpersonal sensitivity than the general population. Among clinic clients, body satisfaction showed positive associations with depressive symptoms, obsessive‐compulsive symptoms, hostility, phobic anxiety, and BMI, and negative associations with anxiety, somatization, interpersonal sensitivity, and paranoia. In the general population, depressive symptoms, somatization, interpersonal sensitivity, and BMI were negatively associated with body satisfaction, whereas anxiety, phobic anxiety, paranoia, and psychoticism were positively associated. Conclusions: Psychological Symptom Dimensions and BMI showed different patterns of association with body satisfaction across populations. Unexpected positive associations observed among clinic clients should be interpreted cautiously given the cross‐sectional design, sampling characteristics, and gender imbalance.